Immunomodulatory activity of malononitrilamides, derivatives of leflunomide's primary metabolite, on models of experimental rheumatoid arthritis

Transplant Proc. 1998 Dec;30(8):4137-9. doi: 10.1016/s0041-1345(98)01371-2.
No abstract available

MeSH terms

  • Acrylamide / therapeutic use
  • Acrylamides*
  • Alkynes
  • Animals
  • Antibodies, Antinuclear / blood
  • Arthritis, Experimental / drug therapy*
  • Arthritis, Experimental / immunology
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Caproates / therapeutic use*
  • Disease Models, Animal
  • Female
  • Immunoglobulin G / blood
  • Immunosuppressive Agents / therapeutic use*
  • Isoxazoles
  • Mice
  • Mice, Mutant Strains
  • Nitriles
  • Rats
  • Rats, Inbred Lew

Substances

  • Acrylamides
  • Alkynes
  • Antibodies, Antinuclear
  • Caproates
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Isoxazoles
  • Nitriles
  • 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide
  • Acrylamide
  • HMR 1279